ArticleBMC genomic data2025
Complete genome sequence and genetic features of a novel Pseudomonas sp. isolate (CAM1A) from tsetse fly gut captured in Dodeo, Cameroon.
Article in BMC genomic data, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Draft genome sequence ofMicrobiology resource announcements · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
Abstract
Bacteria of the genus Pseudomonas are Gram-negative and comprise of at least 107 diverse species. Certain members of the genus Pseudomonas emerged as major opportunistic human pathogens, and others have been used as biocontrol agents. Tsetse flies, the biological vectors of African trypanosomes, harbour diverse communities of microorganisms. Tsetse microbiota is of interest because of their possible effect on vector competence. The aim of this study was to explore genetic features of a novel Pseudomonas species strain CAM1A isolated from tsetse caught in Dodeo, Cameroon. The bacterium was isolated from tsetse fly, and the whole genome was sequenced on the Illumina Miseq platform. Sequences were assembled with SPAdes and annotated using RAST and PATRIC annotation pipelines. The draft genome, made of 61 contigs was found to be at least 5,848,000 bp long, with 5,339 coding sequences, a DNA G + C content of 64.3%, and at least 80 tRNA + rRNA genes. No plasmid was found. Taxonomic analysis based on whole-genome sequences (ANI and GGDC) and MLSA indicated that CAM1A represents a putative novel species closely related to Pseudomonas soli. Several antimicrobial resistance and efflux-mediated resistance genes were predicted, suggesting its ability to evade many antimicrobial therapies. Determination of secondary metabolites within the genome revealed seven different secondary metabolites distributed on 11 biosynthetic gene clusters. Various virulence factors were found, but the isolate was predicted to be a non-human pathogen.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.